PB 44 of 2021

 

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.

Dated 28 April  2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BEN SLADIC

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

 

 


___________________________________________________________________________

1               Name of Instrument

(1)          This instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)

(2)          This instrument may also be cited as PB 44 of 2021.

2               Commencement

This instrument commences on 1 May 2021.

3               Amendment of National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015)

Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).

 

Schedule 1  Amendments

 

[1]           Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)

[2]           Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)

[3]           Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative)

omit:

 

 

 

Norditropin

SimpleXx

D(100)